In the Zone: coronavirus
With coronavirus disease 2019 (COVID-19) shutting down countries and economies, the world is expectantly looking at scientist to come up with a solution. Although the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is fast and deadly, there is a serious arsenal of antivirals the scientific community is charging at SARS-CoV-2. The weaponry includes novel RNA vaccines, broad-spectrum virus inhibitors and even a cell therapy.
Discover the latest updates on the ongoing novel coronavirus outbreak in this ‘In the Zone’. Here, you can discover the latest news headlines and updates, and also read more in-depth articles on the pandemic.
Want to stay updated? Receive the latest news direct to your inbox by becoming a member.
NEWS | LONGER READS | JOURNAL ARTICLES
Latest coronavirus news
- Customizable COVID-19 testing packages launched to help manage and treat virus
- COVID-19 antigen test from Avacta and Adeptrix reaches prototype stage
- Thermo Fisher Scientific collaborate to develop COVID-19 serology test
- Emergency use authorization for Thermo Fisher Scientific’s COVID-19 diagnostic test expanded by US FDA
- Mologic and BioSure partner to produce antibody self-test for COVID-19
- Study indicates new antigen test could help first-line diagnosis of COVID-19
- New collaboration strives for better understanding of cellular mechanisms of COVID-19
- Serological test developed for COVID-19
- Test for SARS-CoV-2 joins arsenal of assays granted emergency use authorization
- International collaboration to develop one-step PCR test for COVID-19
- COVID-19 test: no sample preparation required
- Plasmonic biosensor to detect SARS-CoV-2 in COVID-19 patients
- COVID-19 saliva test from Rutgers granted emergency use authorization by FDA
- Life sciences companies enter international partnership to develop and manufacture rapid test for COVID-19
- COVID-19 diagnostic test enters validation process
- Mobile health platform could improve clinical trial support during COVID-19 pandemic
- COVID-19 monitoring program launched by PRA Health Sciences
- US FDA grants further emergency use authorization for coronavirus assays, bringing total to four
- FDA issue emergency use authorization to Thermo Fisher Scientific for COVID-19 diagnostic test
- Bioanalysis lab prepared by QPS to aid fight against COVID-19
- Assay for safe and easy testing of novel coronavirus in development
- Researchers develop the first diagnostic assay to test suspected cases of novel coronavirus
Visit our sister site The Nanomed Zone for the latest news on nano-based diagnostics for COVID-19.
Longer editorials and insights
- COVID-19 and microsampling: from patient-centric testing to drug development and beyond
- Coronavirus lockdown for bioanalysts: personal and professional challenges
- COVID-19 testing: potential challenges and solutions
- COVID-19 is opening a door to a new era in drug development
- COVID-19 low-cost and laboratory-safe detection protocol
- Coronavirus and bioanalysis: the fight against COVID-19
Articles from Future Science Group journal collection
- Rapid and robust bioanalytical assays are critical for SARS-CoV-2 therapeutic and vaccine development and beyond
Kar S and Islam R, 2020 – Bioanalysis - Exhaled breath condensate as a potential specimen for diagnosing COVID-19
Khoubnasabjafari M, Jouyban-Gharamaleki V, Ghanbari R & Jouyban A, 2020 – Bioanalysis - Managing bioanalytical studies druing the COVID-19 pandemic: an overview
Pruim P, Teekamp N, 2020 – Bioanalysis - Precision mulitparameter tracking of inflammation on timescales of hours to years using serial dried blood spots
Anderson L et al., 2020 – Bioanalysis - High sensitivity methods to quantify chloroquine and its metabolite in human blood samples using LC–MS/MS
Kaewkhao K et al., 2019 – Bioanalysis - Development and validation of an HILIC–MS/MS method by one-step precipitation for chloroquine in miniature pig plasma
Wang K et al., 2016 – Bioanalysis - Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors
Bersanelli M, 2020 – Imunotherapy - Drug repurposing strategies for COVID-19
Senanayake SL, 2020 – Future Drug Discovery - Membrane binding proteins of coronaviruses
Alsaadi and Jones, 2019 – Future Virology - Verification and diagnostic evaluation of the RealStar® Middle East respiratory syndrome coronavirus (N gene) reverse transcription-PCR kit 1.0
Hecht et al., 2019 – Future Microbiology
